Journal of Stroke & Cerebrovascular Diseases
Volume 12, Issue 1 , Pages 37-43 , January 2003

Aspirin “failures,” clopidogrel added to aspirin, and secondary stroke prevention in veterans presenting with TIA or mild-to-moderate ischemic stroke

Received 6 September 2002 ,Accepted 12 November 2002.

References 

  1. Albers GW, Amarenco P, Easton JD, et al.  Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2001;119:300S–320S
  2. Brass LM. Advances in long-term stroke prevention with antiplatelet therapy. J Stroke Cerebrovasc Dis. 2001;10:18S–23S
  3. CAPRIE Steering Committee . A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 1996;348:1329–1339
  4. Biller J. Number of major vascular events prevented by clopidogrel versus other cardiovascular therapies. Neurology. 1998;51:332S; (abstr)
  5. Barnett HJM, Eliasziw M. Special edition: a review of antiplatelet agents meta-analysis. National Stroke Association. Stroke: Clinical Updates. 1998;8:1–6
  6. Gorelick PB, Hanley DF. Clopidogrel and its use in stroke patients (letter). Stroke. 1998;29:1737
  7. Lalouschek W, Lang W, Müllner M. Current strategies of secondary prevention after a cerebrovascular accident. Stroke. 2001;32:2860–2866
  8. Adams HP, Bendixen BH, Kappelle LJ, et al. , the TOAST Investigators   Classification of subtype of acute ischemic stroke. Definition for use in a multicenter clinical trial. Stroke. 1993;24:35–41
  9. Rankin J. Cerebral vascular accidents in patients over the age of 60: II Prognosis. Scot Med J. 1957;2:200–215
  10. Goldstein LB, Bartels C, Davis JN. Interrater reliability of the NIH Stroke Scale. Arch Neurol. 1989;46:660–662
  11. Chimowitz MI, Furlan AJ, Nayak S, et al.  Mechanism of stroke in patients taking aspirin. Neurology. 1990;40:1682–1685
  12. Helgason CM, Tortorice KL, Winkler SR, et al.  Aspirin response and failure in cerebral infarction. Stroke. 1993;24:345–350
  13. Helgason CM, Brelin KM, Hoff JA, et al.  Development of aspirin resistance in persons with previous ischemic stroke. Stroke. 1994;25:2331–2336
  14. Gum PA, Kottke-Marchant K, Poggio ED, et al.  Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001;88:230–235
  15. Sappok T, Faulstich A, Stuckert E, et al.  Compliance with secondary prevention of ischemic stroke. A prospective evaluation. Stroke. 2001;32:1884–1889
  16. Uchiyama S, Sone R, Nagayama T, et al.  Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke. 1989;20:1643–1647
  17. Hall P, Nakamura S, Maiello L, et al.  A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation. 1996;93:215–222
  18. Cadroy Y, Bossavy J-P, Thalamas C, et al.  Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823–2828
  19. Harbison JW, for the Ticlopidine Aspirin Stroke Study Group . Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study. Stroke. 1992;23:1723–1727
  20. The Canadian Cooperative Study Group . A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53–59
  21. Bousser MG, Eschwege E, Haguenau M, et al.  “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke. 1983;14:5–14
  22. Sorensen PS, Pederson H, Marquardsen J, et al.  Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danish cooperative study. Stroke. 1983;14:15–22
  23. Hass WK, Easton JD, Adams HP, et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501–507
  24. Grotta JC, Lemak NA, Gary H, et al.  Does platetelet antiaggregant therapy lessen the severity of stroke?. Neurology. 1985;35:632–636
  25. Sivenius J, Cunha L, Diener HC, et al. , for the European Stroke Prevention Study 2 Working Group   Antiplatelet treatment does not reduce the severity of subsequent stroke. Neurology. 1999;53:825–829
  26. Wilterdink JL, Bendixen B, Adams HP, et al. , for the TOAST Investigators   Effect of prior aspirin use on stroke severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 2001;32:2836–2840
  27. Bornstein NM, Karepov VG, Aronovich BD, et al.  Failure of aspirin treatment after stroke. Stroke. 1994;25:275–277
  28. Bossavy J, Thalamas C, Sagnard L, et al.  A double-blind randomized comparison of combined ticlopidine and aspirin therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood. 1998;92:1518–1525
  29. Popma JJ, Weitz J, Bittl JA, et al.  Antithrombotic therapy in patients undergoing coronary angioplasty. Chest. 1998;114:728S–741S
  30. Harker LA, Marzec UM, Kelly AB, et al.  Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation. 1998;98:2461–2469
  31. Herbert JL, Dol F, Bernat A, et al.  The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost. 1998;80:512–518
  32. Makkar RR, Eigler NL, Kaul S, et al.  Effects of clopidogrel, aspirin, and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis. Eur Heart J. 1998;19:1538–1546
  33. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators . Effect of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  34. Mehta SR, Yusuf S, Peters RJG, et al. , for the Clopidogrel in Unstable Angina to Prevent Recurrent Events trial CURE investigators   Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  35. Moussa I, Oetgen M, Roubin G, et al.  Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation. 1999;99:2364–23366
  36. Nutescu E, Helgason CM. Combination aspirin-clopidogrel therapy in patients with ischemic stroke. Stroke. 2000;31:298; (abstr)
  37. Albers GW, Amarenco P. Combination therapy with clopidogrel and aspirin. Can the CURE results be extrapolated to cerebrovascular patients?. Stroke. 2001;32:2948–2949

☆ Address reprint requests to: Ross L. Levine, MD, Neurology Service/127, Middleton VAH, 2500 Overlook Tr., Madison, WI 53705.

PII: S1052-3057(02)45904-6

doi: 10.1053/jscd.2003.4

Journal of Stroke & Cerebrovascular Diseases
Volume 12, Issue 1 , Pages 37-43 , January 2003

Article Tools